The administration of ISL alone to xenograft animals significantly inhibits lung metastasis in breast cancer and suppresses the expression of matrix metallopeptidase-9/7/2 (MMP-9/7/2), NF-κB, and cyclooxygenase-2 (COX-2) [57,63,64,66]. Here, PTGS2 is linked to breast carcinoma.